Indications
Reversal of neuromuscular blockade induced by rocuronium or vecuronium. For the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in paediatric patients from birth to 17 years.
Composition
- Active substance
- sugammadex sodium
- International name (INN)
- sugammadex
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Sugammadex Amomed
- Active substance
- sugammadex sodium
- ATC code
- V03AB35
- Group
- Various
- Therapeutic area
- Neuromuscular Blockade
- Marketing authorisation holder
- AOP Orphan Pharmaceuticals GmbH